A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance-Reference-Cited by-同舟云学术

A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance

Published:2017-11-27 Issue:1 Volume:78 Page:265-277
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Arnst Kinsie E.,Wang Yuxi,Hwang Dong-Jin,Xue Yi,Costello Terry,Hamilton David,Chen Qiang,Yang Jinliang,Park Frank,Dalton James T.,Miller Duane D.,Li Wei

Funder

NIH/NCI

National Natural Science Foundation of China

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of benzimidazole-2-amide BNZ-111 as new tubulin inhibitor;Bioorganic & Medicinal Chemistry Letters;2024-11

2. Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapy;European Journal of Medicinal Chemistry;2024-10

3. Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer;Cancer Letters;2024-08

4. Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer;2024-05-23

5. Copper(II) Complexes with Isomeric Morpholine-Substituted 2-Formylpyridine Thiosemicarbazone Hybrids as Potential Anticancer Drugs Inhibiting Both Ribonucleotide Reductase and Tubulin Polymerization: The Morpholine Position Matters;Journal of Medicinal Chemistry;2024-05-21